National Cancer Institute Kenya

Blog

  • Kenya Strengthens Regional Cancer Treatment Infrastructure Through Strategic Agreements

    Kenya Strengthens Regional Cancer Treatment Infrastructure Through Strategic Agreements

    Kenya is intensifying efforts to address the rising cancer burden through strengthening critical treatment infrastructure and expanding access to specialized oncology services across the country.

    Today, the Cabinet Secretary for Health, Hon. Aden Duale, presided over the signing of Intergovernmental Participation Agreements (IPAs) and tripartite Service Level Agreements (SLAs) to operationalize regional cancer centres in Mombasa, Garissa, and Nakuru. The NCI-K CEO reaffirmed the Institute’s commitment to strengthening coordinated cancer control efforts.

    NCI-K CEO, Dr. Elias Melly, during the signing of Intergovernmental Participation Agreements (IPAs)

    The agreements establish structured frameworks for preventive maintenance, quality assurance, and timely technical support for essential radiotherapy equipment, particularly linear accelerators, to ensure safe, reliable, and uninterrupted cancer treatment services.

    Aligned with the Universal Health Coverage (UHC) agenda, this initiative seeks to position regional facilities as strong referral hubs, bringing advanced cancer care closer to communities while minimizing delays and service interruptions.

    The Government has also reiterated its commitment to improving cancer treatment financing through the Social Health Authority (SHA), increasing the oncology benefits package to KES 800,000 per patient, benefiting over 29 million registered Kenyans. Strengthened collaboration between national and county governments, together with private sector partners, will be key in building a more responsive and resilient cancer care system.

    The Cabinet Secretary further called upon the Council of Governors and county governments to support these efforts by ensuring adequately trained personnel and a consistent supply of essential consumables, including brachytherapy source wires, thermoplastic masks, and imaging reagents required for daily clinical operations.

  • NCI-K Participates in the 16th KEMRI Annual Scientific & Health (KASH) Conference 2026.

    NCI-K Participates in the 16th KEMRI Annual Scientific & Health (KASH) Conference 2026.

    The NCI-K, represented by the CEO, Dr. Elias Melly, participated in the 16th KEMRI Annual Scientific & Health (KASH) Conference, convened under the theme: “Advancing Kenya’s Vaccine Research, Development and Manufacturing Capacity for Sustainable Health Security.”

    The conference, which brought together leading scientists, policymakers, and global health experts, deliberated on strengthening Kenya’s vaccine ecosystem. Key sessions included a high-level roundtable on success factors in local vaccine manufacturing — spanning research and development, manufacturing capacity, technology transfer and intellectual property, skills development, regulatory pathways, quality standards, access to finance, supply chain systems, and market shaping. Discussions also explored Africa’s Initiative for Local Vaccine Manufacturing and advancing global vaccine end-to-end capabilities.

    The Keynote Address was delivered by Prof. Shaukat Abdulrazak, PhD, EBS, Principal Secretary, State Department of Science, Research and Innovation, Ministry of Health, titled: “Kenya’s Vision and Journey in Local Vaccine Manufacturing.” The Chief Guest, Hon. Dr. Aden Duale, Cabinet Secretary for Health, graced the conference.

    During the conference, Dr. Melly presented on breast cancer incidence trends in Kenya and the role of exposure data in strengthening cancer surveillance, highlighting the importance of leveraging data and research to inform prevention strategies and enhance national cancer control efforts.The forum reaffirmed the central role of research, innovation, and strategic partnerships in advancing health security and improving population health outcomes.

  • NCI-K Supports West Pokot’s 5 Day Cancer Screening Drive to Boost Early Detection.

    The National Cancer Institute of Kenya has commended West Pokot County for the successful implementation of a 5 day cancer screening and awareness exercise at Kapenguria County Referral Hospital, noting that the initiative has expanded access to early detection and prevention services for residents

    The screening programme was conducted from January 31 to February 4, 2026 .This provided cervical, breast and prostate cancer screening services, as well as Human Papillomavirus (HPV) vaccination for eligible girls. The outreach targeted long-standing gaps in access to cancer prevention services in the county, where many cases have historically gone undetected until advanced stages.

    County health leadership emphasized that taking screening services closer to communities is key to reducing late diagnosis and improving outcomes. West Pokot County Executive Committee (CEC) Member for Health, Claire , noted that the exercise aimed to ensure that early detection services reach those who need them most, saying, “When screening services are accessible, we can detect cancer earlier and save more lives.”

    NCI-K underscored that late diagnosis remains a major contributor to cancer-related deaths in Kenya and reaffirmed the importance of making screening a routine health-seeking behavior. NCI-K official Chrisantus Wekesa highlighted the importance of early action, stating, “Cancer is treatable and, in many cases, curable if detected early.”

    The exercise aligned with national and global cancer control priorities, including cervical cancer elimination through screening and HPV vaccination, and demonstrated the value of partnerships between county governments, national institutions, and implementing partners. Community sensitization activities and a solidarity march in Makutano town further reinforced messages on healthy lifestyles, stigma reduction, and the importance of timely screening.

    NCI-K encourages other counties to adopt similar outreach models to expand equitable access to cancer prevention and early detection services, particularly in hard-to-reach communities.

  • KIRINYAGA RECORDS HISTORIC TURNOUT AS NCI-K LEADS CERVICAL CANCER AWARENESS AND SCREENING OUTREACH.

    KIRINYAGA RECORDS HISTORIC TURNOUT AS NCI-K LEADS CERVICAL CANCER AWARENESS AND SCREENING OUTREACH.

    The National Cancer Institute of Kenya (NCI-K), in collaboration with partners including Texas Cancer Centre, Beyond Zero, Minnovate Afya, the County Government of Kirinyaga, and the Office of the Principal Secretary, State Department for Health and Professional Standards – Ministry of Health, conducted a major cancer screening, education, and awareness outreach at Ngiriambu Primary School in Kirinyaga County as part of activities to commemorate Cervical Cancer Awareness Month.

    The outreach was preceded by extensive community mobilization and publicity, resulting in an impressive turnout of both men and women for screening services. Notably, Day One recorded a historic milestone — for the first time across NCI-K screening outreaches, the number of men presenting for screening surpassed that of women. This marks a significant and encouraging shift, demonstrating that men are increasingly taking an active role in seeking healthcare services. The high uptake among men was further supported by the use of modern PSA screening technology, a simple process that delivers results in approximately 15 minutes, improving convenience and confidence in testing.

    The week-long activity is expected to reach even higher numbers as momentum builds. NCI-K commends the community for this positive response and encourages other regions across the country to emulate Kirinyaga’s proactive approach to cancer prevention and early detection.

    In addition to screening services, members of the public received health education and awareness sessions aimed at dispelling myths and misconceptions about cancer while promoting accurate information on prevention, early detection, and treatment options. NCI-K remains committed to reaching communities across the country to enhance uptake of HPV vaccination and cancer screening services as Kenya works toward achieving the WHO 90-70-90 cervical cancer elimination targets by 2030, alongside implementation of the National Cervical Cancer Elimination Action Plan 2025–2030.

  • NCI-K Advances Plans for a National Childhood Cancer Registry.

    NCI-K Advances Plans for a National Childhood Cancer Registry.

    The National Cancer Institute of Kenya (NCI-K) convened a stakeholder meeting to establish a National Childhood Cancer Registry to strengthen pediatric cancer surveillance in the country. The consultative forum was held yesterday, 23rd January, in Nairobi, bringing together key actors in cancer data management and clinical care from across the country.

    Stakeholders and Cancer Registrars from regional centers

    The meeting, chaired by NCI-K Chief Executive Officer, Dr. Elias Melly, brought representations spanning the Nairobi, Nyanza, Nakuru, Rift Valley, Coastal, Central, Eastern, and Northeastern regions, with discussions focused on technical and strategic areas necessary for the successful rollout of the registry. These included a technical session on data variables and standardization, ensuring consistency and quality in reporting across facilities; digital infrastructure and systems integration to support real-time data capture and sharing; and priority research areas and opportunities that the registry will unlock to inform policy, planning, and clinical outcomes.

    NCI-K CEO, Dr. Elias Melly, with Prof. Gertjan Kaspers, Managing Director at Princess Maxima Centre for Paediatric Oncology.

    Cancer registrars from the regional centres presented the status of their respective facilities, highlighting existing capacities, challenges, and areas requiring support; a practical insight expected to guide the phased implementation of the registry and ensure it is responsive to realities on the ground.

    A strong case for an urgent need to develop robust data to improve early diagnosis, treatment planning, survival outcomes, and long-term follow-up for children with cancer was presented by Gladys Chesumbai, the Head of the National Cancer Registry at NCI-K. The sessions benefited from international expertise, with professional guidance provided by Prof. Gertjan Kaspers, Managing Director at the Princess Máxima Centre for Paediatric Oncology. His contribution enriched discussions on global best practices in paediatric oncology data systems and registry development.

    The meeting was further strengthened by the presence of leading medical professionals, including Dr. Gilbert Olbara, Dr. Irene Nzamu, Dr. Rose Munge, Dr. Fatma Al-Amoody, Dr. Grace Mbatia, Dr. Doreen Karimi, Dr. Ann Korir—who also serves as NCI-K Board Member—and Ibrahim El Salih.

    The planned National Childhood Cancer Registry is expected to be a transformative tool in Kenya’s fight against childhood cancer, providing reliable national data to guide prevention strategies, improve care delivery, and support research and resource allocation. This initiative aligns with NCI-K’s broader mandate to strengthen cancer control systems and improve outcomes for all Kenyans.

    Towards a Cancer Free Nation.

  • Kenya Launches National Cervical Cancer Elimination Action Plan 2026–2030

    Kenya Launches National Cervical Cancer Elimination Action Plan 2026–2030

    15th January, 2025 – Nairobi, Kenya

    Abel Limo

    admin

    The National Cancer Institute of Kenya (NCI-K) participated in the official launch of Kenya’s National Cervical Cancer Elimination Action Plan 2026–2030, marking a significant milestone in the country’s efforts to eliminate one of the leading causes of cancer-related deaths among women.

    The launch took place during a National Symposium presided over by the Cabinet Secretary for Health, Hon. Aden Duale, as part of Kenya Cancer Awareness Month. The two-day symposium was held under the theme:
    “Accelerating Cervical Cancer Elimination: Strong Systems and Community Action for Every Girl and Every Woman.”

    Health CS Hon. Aden Duale during the official launch of Kenya’s National Cervical Cancer Elimination Action Plan 2026–2030.

    NCI-K was represented at the symposium by its Chief Executive Officer, Dr. Elias Melly, reaffirming the Institute’s central role in coordinating and strengthening national cancer prevention and control efforts.

    The forum brought together women leaders, healthcare professionals, policymakers, development partners, and civil society organisations to review progress and accelerate action across the full continuum of cervical cancer care — from prevention and screening to diagnosis, treatment, and follow-up.

    This Action Plan is designed to drive progress towards the WHO global 90–70–90 targets:

    • 90% of girls fully vaccinated against HPV
    • 70% of women screened using high-performance tests
    • 90% of women diagnosed with cervical pre-cancer or cancer receiving timely and appropriate treatment

    The Action Plan prioritises HPV vaccination, early and equitable screening, prompt treatment, and long-term follow-up, in alignment with the World Health Organization’s strategy to eliminate cervical cancer as a public health threat.

    NCI-K remains committed to supporting the implementation of this Action Plan through coordination, advocacy, public education, and partnerships aimed at achieving a cervical cancer–free future for all women and girls in Kenya.

  • Building a Cancer-Free Future: How Kenya Is Tackling Cervical Cancer and the Wider Cancer Burden

    Building a Cancer-Free Future: How Kenya Is Tackling Cervical Cancer and the Wider Cancer Burden

    The 90–70–90 targets aim to eliminate cervical cancer by ensuring widespread HPV vaccination, regular screening, and timely treatment for all women. In Kenya, the government—through the Ministry of Health—is actively pursuing these goals as part of a comprehensive cancer control agenda. The strategy sets global targets for 90% of girls vaccinated against HPV by age 15, 70% of women screened with high-performance tests by ages 35 and 45, and 90% of women diagnosed with pre-cancer or cancer receiving appropriate treatment to drastically reduce incidence and deaths within the century.

    Kenya has taken several concrete steps to make this a reality. The Ministry of Health has integrated free HPV vaccination into the national immunization programme across the country and recently transitioned to a single-dose HPV vaccination schedule, which increases coverage and reduces barriers for families. Screening services for cervical, breast, prostate, and other cancers are being expanded through community outreach, county health facilities, and integrated public health campaigns.

    Beyond vaccination and screening, the government is strengthening cancer care infrastructure and access. Through the Social Health Authority (SHA) oncology benefits package, millions of Kenyans receive financial support for cancer diagnosis and treatment, including expensive therapies like HER2+ breast cancer drugs at reduced cost under the SHA scheme. More cancer treatment centres—such as regional and county chemotherapy and radiotherapy units—are being established, and modern diagnostic equipment like mammography and CT scanners are being rolled out to more counties to bring services closer to patients.

    The government’s National Cancer Control Strategy 2023-2027 provides policy guidance across prevention, early detection, diagnosis, treatment, palliative care, and research, emphasizing county partnerships, stakeholder coordination, and financing to improve access and outcomes. Kenya is also strengthening cancer data systems and population-based registries to inform evidence-based policy and improve planning and evaluation of interventions.

    Together, these efforts highlight Kenya’s strong commitment to protecting women and girls and advancing toward a cervical cancer–free future while tackling the broader cancer burden across the country.

  • The Critical Role of Early Detection in Preventing Cervical Cancer

    The Critical Role of Early Detection in Preventing Cervical Cancer

    Cervical cancer is unique because it is one of the most preventable and treatable forms of cancer, provided it is detected early. In Kenya, where cervical cancer remains the leading cause of cancer-related deaths among women, understanding the importance of early detection is a life-saving necessity.

    1. Detection of Pre-Cancerous Lesions

    Cervical cancer does not develop overnight. It typically takes years for persistent high-risk HPV infections to cause changes in cervical cells that eventually lead to cancer.

    • Early screening (via HPV DNA testing or Pap Smears) identifies these “pre-cancerous” lesions before they become malignant.
    • When caught at this stage, simple outpatient procedures can remove the abnormal cells, effectively preventing cancer from ever developing.

    2. Higher Survival Rates

    The stage at which cancer is diagnosed is the single most important predictor of survival.

    • Early Stage: When detected at an early, localized stage, the 5-year survival rate for cervical cancer is over 90%.
    • Late Stage: If the cancer has spread to distant organs (metastatic), the survival rate drops significantly to below 20%. In Kenya, many patients present with Stage III or IV disease, making early detection campaigns a national priority.

    3. Less Invasive and More Affordable Treatment

    Treatment for advanced cervical cancer often requires a combination of radical surgery, chemotherapy, and radiotherapy, which can be physically grueling and financially draining for families.

    • Early Detection: Treatment for early-stage disease is often less invasive, preserves fertility in younger women, and has a much shorter recovery time.
    • Economic Impact: Early intervention is significantly cheaper than managing advanced-stage cancer. Under the Social Health Authority (SHA), early screening and localized treatments are far more cost-effective for both the patient and the healthcare system.

    4. Quality of Life and Fertility Preservation

    For many women in their childbearing years, early detection offers the possibility of fertility-sparing treatments. Advanced cancer treatments often lead to premature menopause or the inability to carry a pregnancy. Early detection ensures that women can survive cancer while maintaining their quality of life and future family goals.

    5. Breaking the Cycle of Mortality in Kenya

    With roughly 9 women dying every day in Kenya from cervical cancer, early detection is the only way to break this cycle. By moving from “symptom-based” care to “screening-based” prevention, we can transform cervical cancer from a death sentence into a manageable—and eventually eliminated—health issue.

    Conclusion: Early detection is not just a medical recommendation; it is an act of empowerment. It shifts the power from the disease back to the individual, ensuring that a diagnosis does not mean the end of a life, but the beginning of a successful recovery.

  • NCI-K Facilitates Implementation and Validation of EWSS Intervention for Childhood Cancer

    NCI-K Facilitates Implementation and Validation of EWSS Intervention for Childhood Cancer

    3rd December, 2025 – Nairobi, Kenya.

    The National Cancer Institute of Kenya hosted representatives from The Hospital for Sick Children (SickKids) in Toronto, and The Faculty of Health Sciences at the University of Nairobi to discuss a research project titled: “An Adapted Early Warning Signs and Symptoms (EWSS) Intervention to Improve Early Recognition and Referral of Childhood Cancers in Kenya and Cameroon.” This is a research project in partnership with the University of Nairobi, Faculty of Health Sciences, and The Hospital for Sick Children (SickKids) in Toronto, Canada.

    This study seeks to generate robust evidence on the feasibility, effectiveness, and cost implications of introducing a context-adapted EWSS intervention. The aim is to equip healthcare providers and policy stakeholders with practical, evidence-based tools and guidance necessary to drastically improve the early detection and timely referral of childhood cancers.

    The project is currently being rolled out across seven pilot counties in Kenya, ensuring broad geographic representation: Machakos, Garissa, Meru, Embu, Nyeri, Murang’a, and Nairobi.

    The meeting, chaired by NCI-K CEO Dr. Elias Melly, aimed to gain a deeper understanding of the implementation context, seeking institutional technical support for anticipated challenges, as well as expert guidance on aligning the intervention with national health priorities.

    The National Cancer Institute of Kenya is committed to reducing the cancer burden across all age groups through evidence-based mitigation for improved childhood cancer outcomes in Kenya.

  • Zimbabwean Delegation Benchmarks at NCI-K to Establish their National Cancer Institute.

    Zimbabwean Delegation Benchmarks at NCI-K to Establish their National Cancer Institute.

    Nairobi, Kenya – 01/12/2025

    The National Cancer Institute of Kenya (NCI-K) today hosted a high-level Zimbabwean delegation for a benchmarking visit to support the creation of a Cancer Institute in Zimbabwe. This collaboration demonstrates both countries’ commitment to advancing cancer control in Africa.

    The Zimbabwean delegation, comprising senior government and regulatory officials, was led by Dr. B.M. Dube, Permanent Secretary in the Office of the President and Cabinet.

    Zimbabwean Delegation.

    The delegates included:

    • Mr. Chiraya Anderson, Chief Director in the Office of the President and Cabinet.
    • Ms. Rudo Karadzandina, Deputy Director in the Office of the President.
    • Dr. Anna Mary Nyakabau, Board Chairperson, Radiation Protection Authority of Zimbabwe.
    • Mr. Edwin Mhukayesango, Deputy Director, Radiation Protection Authority, Ministry of Health, Zimbabwe.
    • Mr. Chafumbwa Tichaona, Deputy Director in the Office of the President and Cabinet.
    • Ms. Edith Muterina, Representative from the Zimbabwean Embassy.

    This high-profile delegation is centrally involved in overseeing, monitoring, and evaluating national development initiatives and strategies, highlighting the priority placed on effective health sector development in Zimbabwe.

    Dr. B.M. Dube – Permanent Secretary, Office of the President and Cabinet, Zimbabwe.

    NCI-K Chief Executive Officer, Dr. Elias Melly, welcomed the visitors at NCI-K headquarters in Nairobi and took them through the mandate of the Institute. Key areas of focus and presentation included:

    1. Institutional Mandate and Governance: A detailed overview of the legal framework and core mandates of the National Cancer Institute of Kenya, including the policies and guidelines developed to aid the national fight against cancer.
    2. Data Management and Informatics: A comprehensive presentation on the implementation and management of the National Cancer Registry system (NaCaRe), highlighting NCI-K’s approach to data collection, research, and informatics for evidence-based decision-making.
    3. Public Awareness and Education: Insights into how NCI-K passes information to the public through the Information, Communication, and Education (ICE) department, focusing on prevention, screening, and education awareness.
    4. Stakeholder Collaboration: A review of NCI-K’s successful strategy for collaborating with national and international stakeholders and partners to facilitate nationwide free cancer screenings.
    5. Cancer Care Financing and Sustainability: Lessons on how Kenya is managing comprehensive cancer care through the oncology package under the newly established Social Health Authority (SHA), focusing on sustainable financing, accessibility, and ensuring equitable treatment access across the population.

    This is a collaborative effort that aims to reduce the cancer burden in Africa through knowledge sharing, a step that will enable the Zimbabwean delegates to gain practical models and lessons learned in organizational structure, policy development, and data-driven cancer control, which will be invaluable as they move forward with establishing their own national institute.

    The National Cancer Institute of Kenya is firmly committed to relentlessly reducing the national cancer burden through proper leadership, deepening partner engagements, and robust public education. The Institute has demonstrated its ability as a regional leader in effective cancer management through the development and implementation of comprehensive frameworks, such as the National Cancer Control Strategy, National Cancer Registry system (NaCaRe), Polices, and the Social Health Authority’s Oncology Package.